Patent · US Active

Pyrimidine-2,4-diamine derivatives for treatment of cancer

US9604937B2 · kind B2 · utility

3Cited by

1References

11Claims

0Family size

Assignee

THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING · SE

Inventors

Martin Scobie · Uppsala, SE
Thomas Helleday · Stockholm, SE
Tobias Koolmeister · Stockholm, SE
Sylvain Jacques · Val-de-Reuil, FR

Key dates

Filing date	Nov 26, 2013
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Nov 26, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.